News & Updates

Children and teens who watch a lot of television often grow to be adults with metabolic syndrome, obesity, or poor fitness, according to a study.

Treatment of gestational diabetes before 20 weeks’ gestation appears to lead to a modestly lower incidence of a composite of adverse neonatal outcomes as compared with no-immediate treatment, with no substantial differences noted for pregnancy-related hypertension or neonatal lean body mass, as reported in a study.

Treatment with the glucagon-like peptide-1 receptor agonist (GLP-1 RA) albiglutide results in fewer cardiovascular events, irrespective of sodium-glucose cotransporter-2 (SGLT2) inhibitor use, among patients with type 2 diabetes (T2D) and cardiovascular disease, according to the post hoc analysis of Harmony Outcomes*.

Eating nuts on a regular basis provides neuroprotective benefits to older adults who are overweight or obese, have metabolic syndrome, and are predisposed to memory loss or confusion, results of a cohort study have shown.

Adherence to a personalized calorie-restricted, weight-loss diet falls short of reducing glycaemic variability (GV) or glycated haemoglobin (HbA1c) relative to a one-size-fits-all low-fat (standardized) diet among patients with prediabetes and moderately controlled type 2 diabetes, a study has shown.

The Seremban Diabetes (SeDia) Cohort Study, the first large-scale diabetes study of its kind in Malaysia has been launched by the Ministry of Health Malaysia (MOH) and International Medical University (IMU). 

In pregnant women with obesity, supplementation with multi-strain probiotics does not appear to have favourable effects on the metabolic or inflammatory biomarkers in mothers and on the body composition of their offspring, according to a study.

Synbiotics V5 and V7 effectively reduce body weight in individuals with obesity or overweight undergoing lifestyle modification, as shown in a study.

A study on adult patients with type 2 diabetes mellitus (T2DM) treated with insulin for at least 6 months showed 2-in-5 patients had lipohypertrophy.